Preimplantation Genetic Diagnosis (PGD) is a genetic test procedure and is performed in conjunction with in vitro fertilization (IVF). PGD helps in detecting the genetic abnormalities either at gene level or at chromosome level before implantation thereby avoiding the transfer of genetically affected embryos. We offer PGD for aneuploidy screening and PGD for chromosome translocation. This is the most common type of PGD analysis to test the embryos using a panel of chromosomes that are commonly involved in miscarriages or trisomic pregnancies.
Embryos screened this way may have a higher rate of implantation, lower spontaneous loss and a reduced risk of trisomic offspring (e.g., Down’s syndrome).
Many international patients are interested in the possibility of determining an embryo’s gender as part of IVF treatment. For most couples, however, the primary goal is different: a successful pregnancy and the selection of the healthiest possible embryos.
Thanks to modern methods in reproductive medicine, embryos can now be genetically tested before embryo transfer. This provides additional information about the embryos’ chromosomes. At the same time, it is also possible to determine whether an embryo is male or female.
For this reason, many patients are interested not only in the possibility of determining the baby’s gender, but also in the benefits of modern genetic testing as part of an IVF or ICSI treatment.
This is one of the most important questions couples face. While researching treatment options online, you will come across many alternatives. However, the most important factor in any treatment is the support provided by the medical team — this includes the experience of both the Doctor and the Embryologists.
Your doctor must design the best treatment plan for you to achieve the optimum number and quality of eggs. At the same time, embryologists must be highly skilled, as the most critical part of the process is performing the embryo biopsy with minimal risk to the embryo and ensuring proper embryo development.
At Cyprus Hope Fertility and Kıbrıs Umut Tüp Bebek, we offer high success rates with our specialist, Op. Dr. Zehra Onar, and our experienced team.
Yes, although the chances of success is based on egg age and sperm quality, carrying out PGD also increase the chances of implantation.
Yes. Stimulation medication is needed to stimulate the antral follicles and encourage them to grow. Once the follicles are of a certain size, the eggs are collected and then sperm is injected into the mature egg for fertilisation.
No. The FISH method screens for chromosomes 13, 18, 21, X and Y and the results of this testing method, advises which embryo is carrying the correct number of the above listed chromosomes. The results of the genetic testing are 99.9% accurate and the results can help to reduce the chances of a baby being born with a chromosomal defect.
As part of Preimplantation Genetic Testing (PGT), specific chromosomes of the embryos can be examined.
Chromosomes 13, 18, and 21, along with the sex chromosomes X and Y, are commonly analysed. The aim of this testing is to obtain additional information about the genetic development of the embryos.
Certain changes in these chromosomes can be associated with known genetic conditions, including:
During this genetic testing, the gender of an embryo can also be determined at the same time.
Alongside classical PGT, modern NGS technology (Next Generation Sequencing) is now also available.
While a conventional test analyses only specific chromosomes, PGT-A using NGS allows all 23 chromosome pairs of an embryo to be examined.
This provides significantly more comprehensive information about the chromosomal structure. At the same time, the sex chromosomes X and Y are also examined, making gender determination possible.
Many patients are therefore interested not only in gender selection, but also in the expanded possibilities of genetic testing for their embryos.
The reasons for this can vary widely.
In some families, gender-linked genetic conditions play a role. Certain genetic changes may occur more frequently in male or female offspring. In such cases, gender determination can be an additional part of treatment planning.
Other patients, after having several children of the same gender, wish for more balanced family planning. Many couples therefore look into the possibilities of gender selection as part of their fertility treatment.
For most patients, however, the wish for a successful pregnancy and a healthy embryo remains the primary focus.
Treatment begins with a detailed medical consultation and a review of all existing preliminary examinations.
Hormonal stimulation of the ovaries follows. This phase usually lasts around 10 to 12 days. During this time, follicle development is regularly monitored by ultrasound.
Once the eggs have reached the desired maturity, egg retrieval takes place. The procedure usually takes only a few minutes and is carried out under sedation.
After egg retrieval, the collected eggs are fertilised in the laboratory using the ICSI method. Many patients first look into the possibilities of In Vitro Fertilization in Cyprus before exploring genetic testing and gender determination in more detail.
The resulting embryos are then cultured and continuously observed in the laboratory for several days.
Depending on the treatment plan, embryo biopsy is carried out during embryonic development. The cells taken are then genetically tested to obtain additional information about the embryos’ chromosomal structure.
Once the results are available, the embryo transfer is planned. The pregnancy test is usually carried out around twelve days after the transfer.
Many patients ask how reliable gender determination is as part of genetic testing.
Since the analysis is based directly on the sex chromosomes X and Y, an embryo’s gender can be determined with very high accuracy. The test is based on genetic information rather than the embryo’s physical characteristics.
Each patient’s individual situation should always be discussed together with the treating medical team.
The cost of IVF with genetic testing and gender determination is one of the most common questions our patients ask.
Since every treatment is planned individually, the actual cost can vary depending on the medical situation, the number of embryos, and the scope of genetic testing required.
Whether a classical PGT test or an expanded PGT-A (NGS) analysis is carried out can also influence the treatment plan.
We are happy to review your medical records and prepare a transparent cost overview tailored to your personal situation.
Many international patients want to know, before beginning treatment, how long they will need to stay in Cyprus.
In most cases, the stay lasts approximately 8 to 10 days. Many preliminary examinations can already be carried out in your home country, so that only the key treatment steps take place on site.
Our team supports you throughout the entire planning process and provides early guidance on all necessary appointments.
Cyprus is today one of the best-known destinations for international fertility treatment.
Many patients value the modern laboratory technology, short waiting times, and personal support throughout the entire treatment process.
In addition, modern reproductive medicine in Cyprus offers numerous treatment options for patients with different medical backgrounds and fertility journeys.
Patients with reduced ovarian reserve often also look into the possibilities of Egg Donation in Cyprus.
Many patients begin their fertility journey with In Vitro Fertilization in Cyprus, before considering additional genetic testing or further treatment options.
When neither the patient’s own eggs nor sperm can be used, many couples also look into the possibilities of Embryo Donation in Cyprus.
Choosing the right fertility clinic is an important step on the path to the child you’ve been hoping for.
At Cyprus Hope Fertility, we place great importance on personal support, transparent communication, and individually tailored treatment plans.
Our experienced team supports you from your first enquiry through to the completion of your treatment, remaining your point of contact throughout the entire process.
Every fertility treatment is planned individually, to create the best possible conditions for a successful pregnancy.
Yes. As part of genetic testing, an embryo’s gender can be determined based on its sex chromosomes.
A classical PGT test analyses specific chromosomes. PGT-A using NGS allows all 23 chromosome pairs of an embryo to be examined.
Genetic testing commonly examines chromosomes 13, 18, and 21, as well as the sex chromosomes X and Y. With PGT-A (NGS), all 23 chromosome pairs can be tested.
Many patients are interested in this possibility. The options available in your individual case should be discussed as part of a personal consultation.
Since the test is based on genetic information, gender can be determined with very high accuracy.
Depending on the treatment plan, the biopsy is carried out during embryonic development and is used for genetic testing of the embryos.
The reasons for this can vary widely.
In some families, gender-linked genetic conditions play a role. Certain genetic changes may occur more frequently in male or female offspring. In such cases, gender determination can be an additional part of treatment planning.
Other patients, after having several children of the same gender, wish for more balanced family planning. Many couples therefore look into the possibilities of gender selection as part of their fertility treatment.
For most patients, however, the wish for a successful pregnancy and a healthy embryo remains the primary focus.
Treatment begins with a detailed medical consultation and a review of all existing preliminary examinations.
Hormonal stimulation of the ovaries follows. This phase usually lasts around 10 to 12 days. During this time, follicle development is regularly monitored by ultrasound.
Once the eggs have reached the desired maturity, egg retrieval takes place. The procedure usually takes only a few minutes and is carried out under sedation.
After egg retrieval, the collected eggs are fertilised in the laboratory using the ICSI method. Many patients first look into the possibilities of In Vitro Fertilization in Cyprus before exploring genetic testing and gender determination in more detail.
The resulting embryos are then cultured and continuously observed in the laboratory for several days.
Depending on the treatment plan, embryo biopsy is carried out during embryonic development. The cells taken are then genetically tested to obtain additional information about the embryos’ chromosomal structure.
Once the results are available, the embryo transfer is planned. The pregnancy test is usually carried out around twelve days after the transfer.
Many patients ask how reliable gender determination is as part of genetic testing.
Since the analysis is based directly on the sex chromosomes X and Y, an embryo’s gender can be determined with very high accuracy. The test is based on genetic information rather than the embryo’s physical characteristics.
Each patient’s individual situation should always be discussed together with the treating medical team.
The cost of IVF with genetic testing and gender determination is one of the most common questions our patients ask.
Since every treatment is planned individually, the actual cost can vary depending on the medical situation, the number of embryos, and the scope of genetic testing required.
Whether a classical PGT test or an expanded PGT-A (NGS) analysis is carried out can also influence the treatment plan.
We are happy to review your medical records and prepare a transparent cost overview tailored to your personal situation.
Many international patients want to know, before beginning treatment, how long they will need to stay in Cyprus.
In most cases, the stay lasts approximately 8 to 10 days. Many preliminary examinations can already be carried out in your home country, so that only the key treatment steps take place on site.
Our team supports you throughout the entire planning process and provides early guidance on all necessary appointments.
Cyprus is today one of the best-known destinations for international fertility treatment.
Many patients value the modern laboratory technology, short waiting times, and personal support throughout the entire treatment process.
In addition, modern reproductive medicine in Cyprus offers numerous treatment options for patients with different medical backgrounds and fertility journeys.
Patients with reduced ovarian reserve often also look into the possibilities of Egg Donation in Cyprus.
Many patients begin their fertility journey with In Vitro Fertilization in Cyprus, before considering additional genetic testing or further treatment options.
When neither the patient’s own eggs nor sperm can be used, many couples also look into the possibilities of Embryo Donation in Cyprus.
Choosing the right fertility clinic is an important step on the path to the child you’ve been hoping for.
At Cyprus Hope Fertility, we place great importance on personal support, transparent communication, and individually tailored treatment plans.
Our experienced team supports you from your first enquiry through to the completion of your treatment, remaining your point of contact throughout the entire process.
Every fertility treatment is planned individually, to create the best possible conditions for a successful pregnancy.